Proteolytic Activity of Human Lymphoid Tumor Cells and Tumor Progression
Author Information
Author(s): ANGELO VACCA, Domenico RIBATTI, ROBERTO RIA, ANTONIO PELLEGRINO, MICHELE BRUNO, FRANCESCA MERCHIONNE, FRANCO DAMMACCO
Primary Institution: University of Bari Medical School
Hypothesis
The study aims to determine the expression and production of MMP-2 and MMP-9 by human lymphoid tumor cells and their correlation with tumor progression.
Conclusion
The study identifies MMPs as important enzymes involved in the degradation of the extracellular matrix by human lymphoid tumors, suggesting that MMP inhibitors may offer new treatment options.
Supporting Evidence
- Patients with active multiple myeloma expressed higher levels of MMP-2 than those with non-active disease.
- MMP-2 and MMP-9 expression increased with advancing stages of mycosis fungoides.
- Both MMP-2 and MMP-9 were secreted in their activated forms by lymphoid tumor cells.
Takeaway
This study found that certain proteins help tumors grow and spread, and blocking these proteins might help treat cancer.
Methodology
The study used in situ hybridization and gelatin-zymography to assess MMP expression and secretion in various human lymphoid tumor cell lines and patient samples.
Participant Demographics
Patients with plasma cell tumors at different progression stages, including those with monoclonal gammopathies of undetermined significance, non-active multiple myeloma, and active multiple myeloma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website